Clinical Trials Directory

Trials / Completed

CompletedNCT00940134

Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.

INGEAR-1: Effects of INtravenous Infusions of PYY3-36 and GLP-1, as Monoinfusion and in Combination, on ad Libitum Energy Intake, Appetite Sensation, and Energy Expenditure in Healthy Obese Subjects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the effects of intravenous infusion of two gastrointestinal hormones, PYY3-36 and GLP-1, alone and in combination, on appetite in healthy obese men. The investigators hypothesize that an intravenous infusion of each hormone alone will decrease food intake at a buffet meal and decrease appetite, and that in combination, there will be a greater decrease in food intake and appetite compared to each hormone alone.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPYY 3-360.8 pmol/kg/min x 3 hours
BIOLOGICALGLP-11.0 pmol/kg/min x 3 hours
BIOLOGICALsaline infusionsaline infusion x 3 hours

Timeline

Start date
2011-03-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2009-07-15
Last updated
2012-06-15

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00940134. Inclusion in this directory is not an endorsement.